Profilo
Thomas Klaue is currently the Chief Executive Officer at INJEX Pharma AG since 2013.
He previously worked as the Chief Financial Officer at MediGene AG.
Posizioni attive di Thomas Klaue
| Società | Posizione | Inizio |
|---|---|---|
INJEX Pharma AG
 INJEX Pharma AG Medical SpecialtiesHealth Technology INJEX Pharma AG manufactures and sells needle free injections. Its product INJEX 30 is a needle free drug delivery system ready to be marketed worldwide to different medical markets. Injex Pharma's product uses in the fields of diabetes mellitus, local anesthesia and dental purposes. The company was founded by Andy Rösch in 1998 and is headquartered in Berlin, Germany. | Chief Executive Officer | 30/06/2013 |
Precedenti posizioni note di Thomas Klaue
| Società | Posizione | Fine |
|---|---|---|
| MEDIGENE AG | Director of Finance/CFO | 19/04/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MEDIGENE AG | Health Technology |
| Aziende private | 1 |
|---|---|
INJEX Pharma AG
INJEX Pharma AG Medical SpecialtiesHealth Technology INJEX Pharma AG manufactures and sells needle free injections. Its product INJEX 30 is a needle free drug delivery system ready to be marketed worldwide to different medical markets. Injex Pharma's product uses in the fields of diabetes mellitus, local anesthesia and dental purposes. The company was founded by Andy Rösch in 1998 and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Thomas Klaue
